Literature DB >> 15086896

Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families.

Eiji Kudo1, Naoyuki Kamatani, Osamu Tezuka, Atsuo Taniguchi, Hisashi Yamanaka, Sachiko Yabe, Dai Osabe, Syuichi Shinohara, Kyoko Nomura, Masaya Segawa, Tatsuro Miyamoto, Maki Moritani, Kiyoshi Kunika, Mitsuo Itakura.   

Abstract

BACKGROUND: Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal-dominant disease characterized by hyperuricemia of underexcretion type, gout, and chronic renal failure. We previously reported linkage on chromosome 16p12 in a large Japanese family designated as family 1 in the present study. Recent reports on the discovery of mutations of the uromodulin (UMOD) gene in families with FJHN encouraged us to screen UMOD mutations in Japanese families with FJHN, including family 1.
METHODS: Six unrelated Japanese families with FJHN were examined for mutations of the UMOD gene by direct sequencing. To confirm the results of the mutation screening, parametric linkage analyses were performed using markers in 16p12 region and around other candidate genes of FJHN.
RESULTS: Five separate heterozygous mutations (Cys52Trp, Cys135Ser, Cys195Phe, Trp202Ser, and Pro236Leu) were found in five families, including family 1. All mutations were co-segregated with the disease phenotype in all families, except for family 1, in which an individual in the youngest generation was found as a phenocopy by the genetic testing. Revised multipoint linkage analysis showed that the UMOD gene was located in the interval showing logarithm of odds (LOD) score above 6.0. One family carrying no mutation in the UMOD gene showed no linkage to the medullary cystic kidney disease type 1 (MCKD1) locus, the genes of hepatocyte nuclear factor-1beta (HNF-1beta), or urate transporters URAT1 and hUAT.
CONCLUSION: Our results gave an evidence for the mutation of the UMOD gene in the majority of Japanese families with FJHN. Genetic heterogeneity of FJHN was also confirmed. Genetic testing is necessary for definite diagnosis in some cases especially in the young generation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086896     DOI: 10.1111/j.1523-1755.2004.00559.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

Authors:  Guillaume Bollée; Karin Dahan; Martin Flamant; Vincent Morinière; Audrey Pawtowski; Laurence Heidet; Didier Lacombe; Olivier Devuyst; Yves Pirson; Corinne Antignac; Bertrand Knebelmann
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

2.  Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find.

Authors:  Gabriele Raffler; Emanuel Zitt; Hannelore Sprenger-Mähr; Mato Nagel; Karl Lhotta
Journal:  Wien Klin Wochenschr       Date:  2016-01-25       Impact factor: 1.704

3.  Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.

Authors:  Sian E Piret; Patrick Danoy; Karin Dahan; Anita A C Reed; Karena Pryce; William Wong; Rosa J Torres; Juan G Puig; Thomas Müller; Peter Kotanko; Karl Lhotta; Olivier Devuyst; Matthew A Brown; Rajesh V Thakker
Journal:  Hum Genet       Date:  2010-10-26       Impact factor: 4.132

Review 4.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

Review 5.  N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases.

Authors:  Franca Serafini-Cessi; Angela Monti; Daniela Cavallone
Journal:  Glycoconj J       Date:  2005-11       Impact factor: 3.009

6.  A case of familial juvenile hyperuricemic nephropathy with novel uromodulin gene mutation, a novel heterozygous missense mutation in Korea.

Authors:  Dong Hun Lee; Jin Kyung Kim; Sook Eui Oh; Jung Woo Noh; Young-Ki Lee
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

Review 7.  Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.

Authors:  Robert Terkeltaub; David A Bushinsky; Michael A Becker
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

8.  Association between genotype and phenotype in uromodulin-associated kidney disease.

Authors:  Jonathan L Moskowitz; Sian E Piret; Karl Lhotta; Thomas M Kitzler; Adam P Tashman; Erin Velez; Rajesh V Thakker; Peter Kotanko
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

9.  A Japanese Family Suffering from Familial Juvenile Hyperuricemic Nephropathy due to a Rare Mutation of the Uromodulin Gene.

Authors:  Mayuka Nakayama; Yasukiyo Mori; Noriyoshi Ota; Mami Ishida; Yayoi Shiotsu; Eiko Matsuoka; Hiroshi Kado; Ryo Ishida; Mayumi Nakata; Takashi Kitani; Keiichi Tamagaki; Chieko Sekita; Atsuo Taniguchi
Journal:  Case Rep Nephrol Urol       Date:  2012-03-14

10.  Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.

Authors:  Siân E Williams; Anita A C Reed; Juris Galvanovskis; Corinne Antignac; Tim Goodship; Fiona E Karet; Peter Kotanko; Karl Lhotta; Vincent Morinière; Paul Williams; William Wong; Patrik Rorsman; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2009-05-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.